Original article by Jessica Gardner
The Australian Financial Review – Page: 19 : 29-Aug-14

Australian-listed Monash IVF has reported a 2013-14 net profit of $A2.6m, compared with a $A14.6m loss in 2012-13. The group’s revenue of $A114m was 18 per cent higher than previously, and earnings were bolstered by acquisitions and demand for IVF-related services. CEO James Thiedeman has indicated that the group plans to expand in Asia

CORPORATES
MONASH IVF GROUP LIMITED – ASX MVF, VIRTUS HEALTH LIMITED – ASX VRT, PRIMARY HEALTH CARE LIMITED – ASX PRY, MACQUARIE GROUP LIMITED – ASX MQG